Steroid injection into neck muscle trigger points versus C2 dorsal root ganglion (nerve) block for chronic cervicogenic headache
Official title: Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Chronic Musculoskeletal Pain(CMP), Chronic Migraine and Cervicogenic Headache
Run by Beijing Tiantan Hospital · NCT07347730 · Data updated 2026-11-12
This trial will test whether steroid injections into neck myofascial trigger points work as well as C2 dorsal root ganglion (nerve) blocks to reduce pain in adults with chronic cervicogenic headache.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 1036 (estimated) |
| Sponsor | Beijing Tiantan Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | December 1, 2025 |
| Main results expected | December 1, 2026 |
| Study ends | June 1, 2027 |
| Registry record updated | January 16, 2026 |
| Trial ID | NCT07347730 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–65 with a clinician-confirmed diagnosis of cervicogenic headache lasting at least 3 months and an NRS pain score of 3 or higher despite conservative medications are ideal candidates.
✕Probably not a fit
Patients with steroid allergy, active infection, severe organ dysfunction, pregnancy or breastfeeding, long-term opioid or steroid therapy, or other major exclusions are unlikely to benefit and are excluded from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, randomized, blinded-outcome, non-inferiority trial comparing two injection treatments for chronic cervicogenic headache. Enrolled adults are randomly assigned to receive either glucocorticoid injection at myofascial trigger points (MTrPs) or dorsal rami/C2 nerve blocks, with procedures performed at a single center. Patients will be followed for up to two years with regular assessments of pain intensity (NRS), attack frequency, and other clinical outcomes. The trial focuses on long-term clinical efficacy and safety of the two injection approaches.
Why it matters
Potential benefit: If successful, the MTrP injection could offer similarly effective, simple, and safer-to-deliver long-term pain relief compared with C2 nerve blocks, improving headache control and quality of life.
How similar studies have gone: Previous domestic and international studies have reported that glucocorticoid injections at MTrPs and occipital/dorsal root nerve blocks can relieve cervicogenic headache, but long-term head-to-head non-inferiority comparisons are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with cervicogenic headache by at least two pain specialists or neurologists; * Disease duration of at least 3 months; * Age between 18 and 65 years; * Numerical Rating Scale (NRS) score ≥ 3 despite conservative pharmacological treatment; * Signed informed consent form. Exclusion Criteria: * History of allergy to trial medications such as corticosteroids; * Alcohol abuse; long-term use of opioids (exceeding 2 weeks or more than 3 days per week for over 1 month); suspected use of sedative or analgesic medications; patients on long-term steroid therapy; * Severe neurological disorders, significant hepatic or renal dysfunction, heart failure, coagulation abnormalities, gastric ulcer, diabetes, inflammatory rheumatic diseases, etc.; * Inability to use pain assessment scales; * Presence of local or systemic infection; * Pregnant or lactating patients.
Where it's running
-
Beijing Tiantan Hospital
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: Fang Luo
- Email: 13611326978@163.com
- Phone: +86 13611326978
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Glucocorticoid injections into myofascial trigger points to treat knee osteoarthritis.
This study will test whether injecting corticosteroid into myofascial trigger points reduces pain and improves function for adults 45 and older with knee osteoarthritis.
-
Post Isometric Relaxation vs Reciprocal Inhibition for Cervicogenic Headache
This study tests whether two gentle neck muscle techniques, post isometric relaxation and reciprocal inhibition, help people with cervicogenic headache more than a standard physical therapy routine.
-
Kaltenborn vs Maitland Mobilization for Cervicogenic Headache
This trial tests whether Kaltenborn mobilization helps people with cervicogenic headache more than Maitland mobilization.
-
Physical profile of cervicogenic headache vs neck pain and healthy people
This observational study tests whether posture, grip strength, muscle stiffness, elasticity, and pressure sensitivity differ among people with cervicogenic headache, chronic neck pain, and healthy controls.
-
Effects of Different Myofascial Release Techniques on Function in Chronic Neck Pain
This trial tests whether manual or self-applied myofascial release, in addition to standard therapy and exercise, can improve function and reduce pain in adults with chronic non-specific neck pain.
-
Ischemic Compression Plus Home Exercise for Non-Specific Neck Pain
This study tests whether adding ischemic compression to a home exercise program helps reduce neck pain and disability more than home exercise alone in adults with non-specific neck pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.